Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,990.00
Bid: 5,000.00
Ask: 5,005.00
Change: 6.00 (0.12%)
Spread: 5.00 (0.10%)
Open: 5,015.00
High: 5,020.00
Low: 4,990.00
Prev. Close: 4,990.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

7 Apr 2017 07:00

RNS Number : 8955B
Intertek Group PLC
07 April 2017
 

 

 

Intertek acquires KJ Tech Services GmbH in Germany

 

Intertek expands services with on-road testing solutions to provide Total Quality Assurance to its automotive clients globally

 

April 7, 2017

Intertek Group plc (Intertek), a Total Quality Assurance provider to a range of industries worldwide, announces that it has completed the acquisition of KJ Tech Services GmbH (KJ Tech), a leading provider of vehicle, component, lubrication and fuel testing services based in Germany.

The KJ Tech portfolio includes full vehicle road fleet testing, data accumulation and analytical assessment for components, systems, lubricant and engine testing, test method development and industry benchmarking. KJ Tech's services are performed locally in Germany and in any location around the world according to customer requirements.

The growing consumer demand for vehicles with higher performance and lower fuel consumption, the increasing complexity of automotive technologies and the tightening of environmental regulations are all expected to drive strong demand for 'on-road' testing in addition to laboratory testing. KJ Tech's on-road vehicle, component and lubricant testing services fully complement Intertek's expertise in providing laboratory-based services to the automotive industry. Intertek is now uniquely positioned to provide a Total Quality Assurance service offering to its automotive clients globally.

KJ Tech, founded in 1989, is based in Griesheim and employs approximately 100 people. The business generated revenues of c. €9.7m in 2016.

Commenting on the acquisition, André Lacroix, Chief Executive Officer of Intertek, said: "As the automotive industry develops increasingly more complex technologies and environmental regulations become more stringent, the testing of vehicles, components and lubricants in all types of driving conditions becomes increasingly more important. KJ Tech's services are therefore highly complementary to Intertek's existing in-lab validation service offerings. With its longstanding experience and track record of excellent customer service we are delighted to welcome the KJ Tech team to Intertek."

A video describing the transaction in more detail can be viewed at www.intertek.com/investors/

- ENDS -

 

Contacts

 

For further information please contact:

 

Josh Egan, Investor Relations

Telephone: +44 (0) 20 7396 3415 investor@intertek.com

 

Jonathon Brill, Oliver Winters, FTI Consulting

Telephone: +44 (0) 20 3727 1000 intertek@fticonsulting.com

 

About Intertek

Total Quality. Assured.

 

Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 42,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

 

www.intertek.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEASLXEFAXEEF
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.